These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR). Ishizuka H; Konno K; Naganuma H; Sasahara K; Kawahara Y; Niinuma K; Suzuki H; Sugiyama Y J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317 [TBL] [Abstract][Full Text] [Related]
4. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter. Yamazaki M; Akiyama S; Ni'inuma K; Nishigaki R; Sugiyama Y Drug Metab Dispos; 1997 Oct; 25(10):1123-9. PubMed ID: 9321514 [TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide. Niinuma K; Takenaka O; Horie T; Kobayashi K; Kato Y; Suzuki H; Sugiyama Y J Pharmacol Exp Ther; 1997 Aug; 282(2):866-72. PubMed ID: 9262353 [TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary transport governs overall elimination of peptidic endothelin antagonists in rats. Kato Y; Akhteruzzaman S; Hisaka A; Sugiyama Y J Pharmacol Exp Ther; 1999 Feb; 288(2):568-74. PubMed ID: 9918560 [TBL] [Abstract][Full Text] [Related]
7. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Masuda M; I'izuka Y; Yamazaki M; Nishigaki R; Kato Y; Ni'inuma K; Suzuki H; Sugiyama Y Cancer Res; 1997 Aug; 57(16):3506-10. PubMed ID: 9270020 [TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary transport mechanism for the cyclopentapeptide endothelin antagonist BQ-123. Shin HC; Kato Y; Yamada T; Niinuma K; Hisaka A; Sugiyama Y Am J Physiol; 1997 May; 272(5 Pt 1):G979-86. PubMed ID: 9176204 [TBL] [Abstract][Full Text] [Related]
9. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats. Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322 [TBL] [Abstract][Full Text] [Related]
10. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats. Sasabe H; Tsuji A; Sugiyama Y J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864 [TBL] [Abstract][Full Text] [Related]
11. Species differences in the transport activity for organic anions across the bile canalicular membrane. Ishizuka H; Konno K; Shiina T; Naganuma H; Nishimura K; Ito K; Suzuki H; Sugiyama Y J Pharmacol Exp Ther; 1999 Sep; 290(3):1324-30. PubMed ID: 10454510 [TBL] [Abstract][Full Text] [Related]
12. Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2. Morikawa A; Goto Y; Suzuki H; Hirohashi T; Sugiyama Y Pharm Res; 2000 May; 17(5):546-52. PubMed ID: 10888306 [TBL] [Abstract][Full Text] [Related]
13. Reduced folate derivatives are endogenous substrates for cMOAT in rats. Kusuhara H; Han YH; Shimoda M; Kokue E; Suzuki H; Sugiyama Y Am J Physiol; 1998 Oct; 275(4):G789-96. PubMed ID: 9756510 [TBL] [Abstract][Full Text] [Related]
14. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. Chu XY; Kato Y; Niinuma K; Sudo KI; Hakusui H; Sugiyama Y J Pharmacol Exp Ther; 1997 Apr; 281(1):304-14. PubMed ID: 9103511 [TBL] [Abstract][Full Text] [Related]
15. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Paulusma CC; van Geer MA; Evers R; Heijn M; Ottenhoff R; Borst P; Oude Elferink RP Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):393-401. PubMed ID: 10024515 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide. Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360 [TBL] [Abstract][Full Text] [Related]
17. Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats. Chu XY; Kato Y; Sugiyama Y Cancer Res; 1997 May; 57(10):1934-8. PubMed ID: 9157988 [TBL] [Abstract][Full Text] [Related]
18. Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes. Roelofsen H; Bakker CT; Schoemaker B; Heijn M; Jansen PL; Elferink RP Hepatology; 1995 Jun; 21(6):1649-57. PubMed ID: 7768511 [TBL] [Abstract][Full Text] [Related]
19. Decreased hepatobiliary secretion of inorganic mercury, its deposition and toxicity in the Eisai hyperbilirubinemic rat with no hepatic canalicular organic anion transporter. Sugawara N; Lai YR; Sugaware C; Arizono K Toxicology; 1998 Feb; 126(1):23-31. PubMed ID: 9585089 [TBL] [Abstract][Full Text] [Related]
20. Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat. Sasabe H; Kato Y; Tsuji A; Sugiyama Y J Pharmacol Exp Ther; 1998 Feb; 284(2):661-8. PubMed ID: 9454812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]